drugset / Trial / NCT06575478
Evaluation of Fuling Yunhua Granules and Dihuang Baoyuan Granules in Drug Naive Type 2 Diabetes Patients
Phase 2
Recruiting
72 enrolled
Beijing Supreme Life Pharmaceutical Technology Co., Ltd.
Peking University People's Hospital · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
The goal of this investigator-initiated clinical trial is to investigate the efficacy and safety of sequential therapy of Fuling Yunhua Granules (prescription A) and Dihuang Baoyuan Granule (prescription B) in the treatment of type 2 diabetes patients with poor glycemic control after diet and exercise intervention.
Timeline
- Start
- 2024-07-31
- Primary completion
- 2025-01-30
- Completion
- 2025-01-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dihuang Baoyuan Granules | Unknown | — | — |
| Subject | Fuling Yunhua Granules | Unknown | — | — |